Global Multi-Cancer Detection Blood Test Market Growth 2025-2031

The global Multi-Cancer Detection Blood Test market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The Multi-Cancer Detection Blood Test, also known as a liquid biopsy or pan-cancer test, is a type of medical test that aims to detect multiple types of cancer in the body using a blood sample. Unlike traditional cancer screenings that focus on specific cancer types, this test is designed to provide a more comprehensive assessment by detecting various cancer-related biomarkers or genetic alterations present in the bloodstream.

The Multi-Cancer Detection Blood Test holds promise for early cancer detection, as it can potentially identify cancers at an earlier stage when treatment options are more effective and outcomes are better. It may also aid in monitoring cancer patients during treatment and post-treatment to detect recurrence or treatment response.

United States market for Multi-Cancer Detection Blood Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Multi-Cancer Detection Blood Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Multi-Cancer Detection Blood Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Multi-Cancer Detection Blood Test players cover Galleri, Amadix, Burning Rock, Exact Sciences, Freenome, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Multi-Cancer Detection Blood Test Industry Forecast” looks at past sales and reviews total world Multi-Cancer Detection Blood Test sales in 2024, providing a comprehensive analysis by region and market sector of projected Multi-Cancer Detection Blood Test sales for 2025 through 2031. With Multi-Cancer Detection Blood Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multi-Cancer Detection Blood Test industry.

This Insight Report provides a comprehensive analysis of the global Multi-Cancer Detection Blood Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Multi-Cancer Detection Blood Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multi-Cancer Detection Blood Test market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multi-Cancer Detection Blood Test and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multi-Cancer Detection Blood Test.

This report presents a comprehensive overview, market shares, and growth opportunities of Multi-Cancer Detection Blood Test market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
ctDNA-Based Tests
Protein Biomarker-Based Tests
Methylation-Based Tests
Others

Segmentation by Application:
Hospitals
Diagnostic Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Galleri
Amadix
Burning Rock
Exact Sciences
Freenome
AnchorDx
Guardant Health
Foundation Medicine
GENECAST
Coyne Medical
Laboratory for Advanced Medicine
Singlera Genomics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Multi-Cancer Detection Blood Test market?

What factors are driving Multi-Cancer Detection Blood Test market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Multi-Cancer Detection Blood Test market opportunities vary by end market size?

How does Multi-Cancer Detection Blood Test break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.